We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study

    Chronic myelomonocytic leukaemia (CMML) is a haematological malignancy with a poor prognosis. Allogeneic haematopoietic stem cell transplantation...

    Shuhei Kurosawa, Yoshimitsu Shimomura, ... Hidehiro Itonaga in Bone Marrow Transplantation
    Article 08 February 2024
  2. Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation

    The “human leukocyte antigen (HLA) supertype” is a functional classification of HLA alleles, which was defined by structural features and peptide...

    Takeshi Sugio, Naoyuki Uchida, ... Koji Kato in Bone Marrow Transplantation
    Article 18 January 2024
  3. Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation

    The number of umbilical cord blood transplantation (U-CBT) procedures has been growing annually, but little research has been done on long-term...

    Keiko Tsumita, Shinsuke Takagi, ... Yukako Koike in International Journal of Hematology
    Article 26 February 2024
  4. Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging

    Cord blood is an important donor source for allogeneic hematopoietic stem cell transplantation (allo-HSCT), with its unique composition and quality...

    Hiroaki Araie, Naoko Hosono, ... Takahiro Yamauchi in International Journal of Hematology
    Article Open access 02 October 2023
  5. Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation

    HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide (PTCy-haplo) and umbilical cord blood transplantation (UCBT) are...

    Junichi Sugita, Yoshiko Atsuta, ... Takanori Teshima in Bone Marrow Transplantation
    Article 20 August 2022
  6. Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome

    Allogenic hematopoietic stem cell transplantation (allo-HSCT) is not a standard therapy for solid cancer because of its high toxicity and...

    Naokazu Nakamura, Nao Yamamoto, ... Nobuyoshi Arima in International Journal of Hematology
    Article 25 March 2024
  7. Clinical implications of augmented renal clearance after unrelated single cord blood transplantation in adults

    Augmented renal clearance (ARC) is a phenomenon characterized by increased renal functionality, which can impact the pharmacokinetics and...

    Takaaki Konuma, Kosuke Takano, ... Yasuhito Nannya in International Journal of Hematology
    Article Open access 18 October 2023
  8. Feasibility and safety of the discontinuation of systemic immunosuppressive treatment after single-unit cord blood transplantation in adults

    We retrospectively evaluated the incidence, factors, and clinical outcomes of the discontinuation of immunosuppressive treatment (IST) after...

    Takaaki Konuma, Maki Monna-Oiwa, ... Satoshi Takahashi in Bone Marrow Transplantation
    Article Open access 13 May 2024
  9. Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial

    Coinfusion of unrelated cord blood (UCB) units in haploidentical hematopoietic cell transplantation (haplo-HCT) (haplo-cord HCT) for hematopoietic...

    Biqi Zhou, Jia Chen, ... Depei Wu in Signal Transduction and Targeted Therapy
    Article Open access 06 May 2024
  10. Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series

    Objective

    This study aimed to investigate the prognosis of unrelated umbilical cord blood transplantation (UCBT) using low-dose anti-thymocyte...

    Mengze Hu, Junhui Li, ... Litian Xuan in Annals of Hematology
    Article 24 April 2024
  11. Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial

    Graft failure and delayed hematopoietic recovery are the major limitations of cord-blood transplantation (CBT). Romiplostim, a...

    Naoki Kurita, Hidekazu Nishikii, ... Shigeru Chiba in Annals of Hematology
    Article 17 August 2023
  12. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies

    This study aimed to investigate the kinetics of immune recovery following umbilical cord blood transplantation (UCBT) in adults who received a...

    Lourdes Cordón, Pedro Chorão, ... Jaime Sanz in Annals of Hematology
    Article 18 April 2024
  13. A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation

    Natural killer (NK) cell based immunotherapy is an emerging strategy in hematologic malignancies because allogeneic NK cells can provide potent...

    Yuling Wu, Yue Wang, ... Ting Liu in Annals of Hematology
    Article 29 September 2023
  14. Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis

    Background or Purpose

    Although human umbilical cord blood-derived mesenchymal stem cell transplantation (HUCB-MSCT) resulted in a good short-term...

    Zepeng Li, **aoling Zhou, ... **aoling Chi in Journal of Gastrointestinal Surgery
    Article Open access 26 January 2023
  15. Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT

    Graft failure has remained a limitation of umbilical cord blood transplantation (CBT). Here, we assessed the outcomes of patients who experienced...

    Frédéric Baron, Annalisa Ruggeri, ... Mohamad Mohty in Bone Marrow Transplantation
    Article 10 May 2023
  16. Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients

    Bacterial meningitis is a rare but severe infectious complication after hematopoietic stem cell transplantation. However, its clinical features were...

    Takashi Oyama, Kosei Kageyama, ... Shuichi Taniguchi in International Journal of Hematology
    Article 06 August 2022
  17. A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia

    Although killer Ig-like receptor ligands (KIR-L) mismatch has been associated with alloreactive natural killer cell activity and potent...

    Hisashi Ishida, Yuta Kawahara, ... Hirotoshi Sakaguchi in Journal of Hematology & Oncology
    Article Open access 29 April 2024
  18. Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia

    Cord blood transplantation (CBT) is an alternative donor transplantation method and has the advantages of rapid availability and the possibility of...

    Yoshimitsu Shimomura, Tomotaka Sobue, ... Masamitsu Yanada in Leukemia
    Article 24 November 2021
Did you find what you were looking for? Share feedback.